These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 30684155)
1. Current state-of-the-art in plant-based antibody production systems. Donini M; Marusic C Biotechnol Lett; 2019 Mar; 41(3):335-346. PubMed ID: 30684155 [TBL] [Abstract][Full Text] [Related]
2. Biopharmaceutical discovery and production in yeast. Meehl MA; Stadheim TA Curr Opin Biotechnol; 2014 Dec; 30():120-7. PubMed ID: 25014890 [TBL] [Abstract][Full Text] [Related]
3. Clarification technologies for monoclonal antibody manufacturing processes: Current state and future perspectives. Singh N; Arunkumar A; Chollangi S; Tan ZG; Borys M; Li ZJ Biotechnol Bioeng; 2016 Apr; 113(4):698-716. PubMed ID: 26302443 [TBL] [Abstract][Full Text] [Related]
4. Virus-based pharmaceutical production in plants: an opportunity to reduce health problems in Africa. Bamogo PKA; Brugidou C; Sérémé D; Tiendrébéogo F; Djigma FW; Simpore J; Lacombe S Virol J; 2019 Dec; 16(1):167. PubMed ID: 31888686 [TBL] [Abstract][Full Text] [Related]
5. Antibody Production in Plants and Green Algae. Yusibov V; Kushnir N; Streatfield SJ Annu Rev Plant Biol; 2016 Apr; 67():669-701. PubMed ID: 26905655 [TBL] [Abstract][Full Text] [Related]
6. Stable miRNA overexpression in human CAP cells: Engineering alternative production systems for advanced manufacturing of biologics using miR-136 and miR-3074. Weis BL; Guth N; Fischer S; Wissing S; Fradin S; Holzmann KH; Handrick R; Otte K Biotechnol Bioeng; 2018 Aug; 115(8):2027-2038. PubMed ID: 29665036 [TBL] [Abstract][Full Text] [Related]
7. Aggregates in monoclonal antibody manufacturing processes. Vázquez-Rey M; Lang DA Biotechnol Bioeng; 2011 Jul; 108(7):1494-508. PubMed ID: 21480193 [TBL] [Abstract][Full Text] [Related]
8. Model-directed engineering of "difficult-to-express" monoclonal antibody production by Chinese hamster ovary cells. Pybus LP; Dean G; West NR; Smith A; Daramola O; Field R; Wilkinson SJ; James DC Biotechnol Bioeng; 2014 Feb; 111(2):372-85. PubMed ID: 24081924 [TBL] [Abstract][Full Text] [Related]
9. Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks. Sabalza M; Christou P; Capell T Biotechnol Lett; 2014 Dec; 36(12):2367-79. PubMed ID: 25048244 [TBL] [Abstract][Full Text] [Related]
10. The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing. Fisher AC; Kamga MH; Agarabi C; Brorson K; Lee SL; Yoon S Trends Biotechnol; 2019 Mar; 37(3):253-267. PubMed ID: 30241924 [TBL] [Abstract][Full Text] [Related]
11. Using transgenic plants and modified plant viruses for the development of treatments for human diseases. Loh HS; Green BJ; Yusibov V Curr Opin Virol; 2017 Oct; 26():81-89. PubMed ID: 28800551 [TBL] [Abstract][Full Text] [Related]
12. Molecular farming of human cytokines and blood products from plants: challenges in biosynthesis and detection of plant-produced recombinant proteins. da Cunha NB; Vianna GR; da Almeida Lima T; Rech E Biotechnol J; 2014 Jan; 9(1):39-50. PubMed ID: 24376137 [TBL] [Abstract][Full Text] [Related]
15. Towards molecular farming in the future: moving from diagnostic protein and antibody production in microbes to plants. Fischer R; Drossard J; Commandeur U; Schillberg S; Emans N Biotechnol Appl Biochem; 1999 Oct; 30(2):101-8. PubMed ID: 10512787 [TBL] [Abstract][Full Text] [Related]
16. Bench-Scale Stirred-Tank Bioreactor for Recombinant Protein Production in Chinese Hamster Ovary (CHO) Cells in Suspension. Monteil DT; Kuan J Methods Mol Biol; 2018; 1850():133-145. PubMed ID: 30242685 [TBL] [Abstract][Full Text] [Related]
17. New areas of plant-made pharmaceuticals. Hassan SW; Waheed MT; Lössl AG Expert Rev Vaccines; 2011 Feb; 10(2):151-3. PubMed ID: 21332263 [TBL] [Abstract][Full Text] [Related]